4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-008715
Options or other derivatives
- Interim CEO acquired 238,420 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| SMITH IAN F Interim CEO | 2025-03-20 | Grant or award · Stock Option (Right to Buy) | +238,420 | 238,420 | D | ||
Loading xslF345X05/form4-03202025_100340.xml…